HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Role of Nanotechnology in Cancer Diagnosis and Treatment

Nanotechnology has emerged as a transformative tool in cancer diagnosis and treatment, offering unique solutions for targeting and eliminating tumors. Nanoparticles can be engineered to specifically bind to cancer cells, allowing for targeted drug delivery that minimizes damage to surrounding healthy tissue. This precision makes treatments more effective while reducing side effects. Additionally, nanoparticles can be used for imaging, helping to detect tumors at earlier stages and monitor treatment progress. Beyond drug delivery, nanomaterials can also enhance the effectiveness of radiation therapy, concentrating the energy at the tumor site. These advances in nanotechnology hold great potential for improving cancer treatment by providing more personalized and efficient therapeutic strategies.

Committee Members
Speaker at International Conference on Clinical & Translational Oncology 2026 - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
ICTO 2026 Speakers
Speaker at International Conference on Clinical & Translational Oncology 2026 - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Speaker at International Conference on Clinical & Translational Oncology 2026 - Sergey Suchkov

Sergey Suchkov

N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Speaker at International Conference on Clinical & Translational Oncology 2026 - Shinya Tajima

Shinya Tajima

National Hospital Organization Shizuoka Medical Centre, Japan
Speaker at International Conference on Clinical & Translational Oncology 2026 - Nayara Delgado Andre

Nayara Delgado Andre

Federal University of São João del-Rei (UFSJ), Brazil
Tags

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp